rs200779877
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014629.4(ARHGEF10):c.3589C>T(p.His1197Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000323 in 1,613,974 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014629.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF10 | NM_014629.4 | c.3589C>T | p.His1197Tyr | missense_variant | 29/29 | ENST00000349830.8 | NP_055444.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF10 | ENST00000349830.8 | c.3589C>T | p.His1197Tyr | missense_variant | 29/29 | 1 | NM_014629.4 | ENSP00000340297.3 | ||
KBTBD11-OT1 | ENST00000635855.1 | n.*3543C>T | non_coding_transcript_exon_variant | 30/30 | 5 | ENSP00000489726.1 | ||||
KBTBD11-OT1 | ENST00000635855.1 | n.*3543C>T | 3_prime_UTR_variant | 30/30 | 5 | ENSP00000489726.1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000326 AC: 82AN: 251392Hom.: 1 AF XY: 0.000324 AC XY: 44AN XY: 135908
GnomAD4 exome AF: 0.000330 AC: 483AN: 1461768Hom.: 3 Cov.: 31 AF XY: 0.000340 AC XY: 247AN XY: 727192
GnomAD4 genome AF: 0.000256 AC: 39AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74350
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 06, 2022 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 1197 of the ARHGEF10 protein (p.His1197Tyr). This variant is present in population databases (rs200779877, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ARHGEF10-related conditions. ClinVar contains an entry for this variant (Variation ID: 377194). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ARHGEF10 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Feb 06, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.3589C>T (p.H1197Y) alteration is located in exon 29 (coding exon 28) of the ARHGEF10 gene. This alteration results from a C to T substitution at nucleotide position 3589, causing the histidine (H) at amino acid position 1197 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at